Monday, August 24, 2026

HLB Panagene to Highlight Potential of Artificial Nucleic Acid PNA in Drug Development in U.S.

HLB Panagene will showcase its proprietary PNA technology and its potential for next-generation drug development at a major U.S. oligonucleotide and peptide conference.

Why 80% of Companies Want to Reopen Kaesong Industrial Complex: A Deep Dive into the Benefits

Reopening the Kaesong Industrial Complex could enhance inter-Korean relations, with 80% of former companies eager to return.

North Korea Condemns ‘Imperialist Coercion’ at Global Parliamentary Forum in Geneva

North Korea's Rodong Sinmun highlights the 80th anniversary of liberation, condemns imperialist actions, and promotes economic targets.

Tag: epilepsy

How the SIALAP System Revolutionizes Preclinical Trials for Drug-Resistant Epilepsy

Researchers developed an objective framework for matching animal models to specific types of drug-resistant epilepsy, potentially improving the accuracy of preclinical drug development.

How SK Life Science is Bridging Communication Gaps in Epilepsy Management

SK Life Science will present findings on epilepsy treatment and patient-provider communication at the 2026 AAN Annual Meeting in Chicago.

Exploring Cenobamate: How SK Biopharmaceuticals’ New Oral Suspension Benefits Adult Epilepsy Patients

SK Biopharmaceuticals submits NDA for Cenobamate oral suspension, enhancing treatment options for epilepsy patients with swallowing difficulties.

Top News

- Our Sponsors Ad -

Follow us